Eagle launches $50.25m IPO; Incyte, Seattle Genetics rise on 4Q earnings; Ventrus sinks on diltiazem data; Dermira lays out skin study plans; AMAG, Puma, Ophthotech, Ironwood and Oxigene raise cash.
written on 13.02.2014
BioNotebook: Eagle IPO; Incyte, Seattle Genetics earnings; Ventrus data; Dermira update; and a flood of financings
